Collectively, our findings indicate that (i) evaluating SOCS1 protein expression may have a prognostic significance in PCa, however this requires development of highly specific and sensitive clinical grade antibodies, and (ii) MET and p21, which are partly regulated by SOCS1, may also be useful in identifying aggressive cancers. Here, SOCS1 is linked to posterior cortical atrophy.